Adn-388 Jun 2026

Preclinical studies have demonstrated the efficacy and safety of ADN-388 in models of various cancers, including NSCLC, gastric cancer, and pancreatic cancer. In these studies, ADN-388 exhibited potent anti-tumor activity, inhibiting tumor growth and extension in animal models. Additionally, ADN-388 was well-tolerated, with minimal toxicity and side effects observed.

: Another theory posits that ADN-388 is a codename for a secretive project or a cutting-edge technology under development. This could range from a new type of malware or hacking tool to an advanced encryption method or even a sophisticated AI algorithm. adn-388

: A few open-source projects and code repositories contain references to ADN-388, often within comments or TODO sections. These references are typically vague, suggesting that ADN-388 might be a placeholder or a reference to an external resource. : Another theory posits that ADN-388 is a

| Model | Treatment | TGI (Day 21) | Median Survival (days) | |-------|-----------|--------------|------------------------| | MC38 | Vehicle | 0 % | 22 | | MC38 | ADN‑388 10 mg kg⁻¹ | 45 % | 28 | | MC38 | ADN‑388 30 mg kg⁻¹ | | 38 | | MC38 | anti‑PD‑1 These references are typically vague